Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation

Revista brasileira de hematologia e hemoterapia
Navneet S MajhailAndré Tichelli

Abstract

Advances in hematopoietic cell transplantation (HCT) technology and supportive care techniques have led to improvements in long-term survival after HCT. Emerging indications for transplantation, introduction of newer graft sources (e.g. umbilical cord blood) and transplantation of older patients using less intense conditioning regimens have also contributed to an increase in the number of HCT survivors. These survivors are at risk for developing late complications secondary to pre-, periand post-transplant exposures and risk-factors. Guidelines for screening and preventive practices for HCT survivors were published in 2006. An international group of transplant experts was convened in 2011 to review contemporary literature and update the recommendations while considering the changing practice of transplantation and international applicability of these guidelines. This review provides the updated recommendations for screening and preventive practices for pediatric and adult survivors of autologous and allogeneic HCT.

References

Jun 15, 1995·International Journal of Radiation Oncology, Biology, Physics·M C BenyunesR Witherspoon
Dec 15, 1993·Annals of Internal Medicine·André TichelliB Speck
Dec 22, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·C de BrabanderM J van den Bent
Aug 11, 2001·Lancet·N SaloojaLate Effects Working Party of the European Group for Blood and Marrow Transplantation
Aug 11, 2001·Bone Marrow Transplantation·D S RitchieA P Grigg
Jul 9, 2002·British Journal of Haematology·Bernadette M D Brennan, Stephen M Shalet
Oct 16, 2002·Bone Marrow Transplantation·Daniel CourielR Champlin
Oct 25, 2003·Blood·Régis Peffault de LatourGérard Socié
Nov 25, 2003·Blood·Claudia M S Schulte, Dietrich W Beelen
Apr 6, 2004·Clinics in Chest Medicine·Kenneth T YenCharles D Burger
May 6, 2004·Pediatric Transplantation·Jean E Sanders
Apr 7, 2005·Bone Marrow Transplantation·M B RankePDWP of the BMT
Apr 20, 2005·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Neal R BarshesJohn A Goss
Aug 9, 2005·Bone Marrow Transplantation·M Booth-JonesE Soety
Sep 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karen SyrjalaPaul J Martin
Dec 13, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Alexandra H FilipovichMary E Flowers
May 17, 2006·Annals of Internal Medicine·Sook-Bin WooJohn R Kalmar
Aug 11, 2006·Current Opinion in Ophthalmology·Stella K Kim
Nov 23, 2006·Blood·Berthe M P AlemanFlora E van Leeuwen
Nov 30, 2006·Annual Review of Immunology·Lisbeth A WelniakWilliam J Murphy
Feb 10, 2007·Bone Marrow Transplantation·S HingoraniG B McDonald
Apr 24, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Bipin N SavaniA John Barrett
Apr 29, 2008·Bone Marrow Transplantation·Navneet S MajhailL J Burns
Oct 31, 2008·Blood·J Douglas RizzoH Joachim Deeg
Jul 16, 2009·JAMA : the Journal of the American Medical Association·Kirsten M WilliamsSteven Z Pavletic
Sep 15, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·M TomblynCenters for Disease Control and Prevention

Citations

Mar 31, 2009·L' Orthodontie française·Claire Averlant-Dubois
Apr 7, 2007·The Review of Scientific Instruments·David K Hilton, Steven W Van Sciver
Jun 3, 2010·The Review of Scientific Instruments·K LämmleR Wiesendanger
Feb 9, 2011·Diabetes Technology & Therapeutics·Dongyuan XingJuvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
Mar 1, 2011·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·L David WaterburyDavid A Hollander
Jan 1, 1947·Anaesthesia·T DINSDALE
Jul 1, 1947·Anaesthesia·R R MACINTOSH, W W MUSHIN
Jul 1, 1947·Anaesthesia·M H A DAVISON
Oct 1, 1948·Anaesthesia·H W C GRIFFITHS, J GILLIES
Oct 1, 1948·Anaesthesia·W W MUSHIN
Jan 1, 1949·Anaesthesia·P J HELLIWELL, A M HUTTON
Apr 1, 1951·Anaesthesia·H A CONDON
Apr 1, 1951·Anaesthesia·M SWERDLOW, M LIPWORTH
Apr 1, 1951·Anaesthesia·G HARRISON
Jul 1, 1951·Anaesthesia·J J L ABLETTG C STEEL
Jan 1, 1951·Anaesthesia·D RECKLESS
Jul 1, 1952·Anaesthesia·R BRYCE-SMITH
Oct 1, 1953·Anaesthesia·J W DUNDEE
Oct 1, 1953·Anaesthesia·M H DAVISON
Jan 1, 1953·Anaesthesia·P WOLFERS
Apr 1, 1953·Anaesthesia·G S A KNOWLES
Jan 1, 1955·Anaesthesia·W H COLE
Jul 1, 1955·Anaesthesia·W H GALLOWAY, H B WILSON
Apr 1, 1958·Anaesthesia·J V MITCHELL, G M WHITE
Apr 1, 1959·Anaesthesia·J G MATHESONJ D WHITBY
Apr 1, 1959·Anaesthesia·T M YOUNG, A B LODGE
Dec 1, 1960·The British Journal of Clinical Practice·A R HUNTER
Jan 1, 1960·Anaesthesia·V P SMOLNIKOFF
Apr 1, 1962·Anaesthesia·M COOKE, R BRYCE-SMITH
Jul 1, 1962·Anaesthesia·D D MOIR
Apr 1, 1964·Anaesthesia·J R JENKINS, W M EDGAR
Apr 1, 1964·Anaesthesia·A R DEACOCK, W T SIMPSON
Jul 1, 1964·Anaesthesia·G W BURTON
Jul 1, 1964·Anaesthesia·R C NAINBY-LUXMOORE
Oct 1, 1965·Anaesthesia·R Binning
Jan 1, 1967·Anaesthesia·A Singh
Jan 1, 1968·Anaesthesia·V Goldman
Apr 1, 1968·Anaesthesia·A W Grogono, A E Jones
Jan 1, 1970·Anaesthesia·T A Thomas, J W Brooks
Apr 1, 1970·Anaesthesia·B R Doran, R A Burt
Jul 1, 1970·Anaesthesia·P Daly

Methods Mentioned

BETA
PCR
biopsy
hormone replacement therapy
testosterone replacement therapy
contraception

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.

Related Papers

Hematology/oncology and Stem Cell Therapy
Navneet S MajhailSociedade Brasileira de Transplante de Medula Ossea (SBTMO)
Bone Marrow Transplantation
Navneet S MajhailSociedade Brasileira de Transplante de Medula Ossea
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Navneet S MajhailSociedade Brasileira de Transplante de Medula Ossea (SBTMO)
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
J R WingardGérard Socié
© 2021 Meta ULC. All rights reserved